NCT02595866 2024-08-09Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerNational Cancer Institute (NCI)Phase 1 Completed58 enrolled 17 charts
NCT00112593 2017-05-24Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerFred Hutchinson Cancer CenterPhase NA Completed5 enrolled 6 charts